Inhibikase Therapeutics, Inc. Common Stock
$2.06
▼ 0.04
(-1.91%)
Volume: 447,227
· 2026-09-25
Loading…
RSI (14)
🧭 Style Verdicts
🚀
Momentum
32
- 21d momentum -17.3%
- RSI 34
🎯
Pullback
63
- RSI 34 near lows
- Near lower Bollinger band
- -11.6% vs 20MA
💎
Value
58
- -21% off 52w high
Scores (0–100) derived from live technical & fundamental metrics. Not investment advice.
📐 Technicals
RSI(14)33.6
MACD-0.038
MA trendMixed
ATR5.36%
21d mom.-17.3%
63d mom.+7.8%
vs 20MA-11.6%
RVOL(20)0.84×
52w low · 1
52w high · 3
-21.1% from 52-week high
20d support 2
· resistance 3
Computed live from daily OHLCV · as of 2026-09-25
🏦 Fundamentals
Market cap$293M
PER—
PBR1.91
PSR—
EPS$-0.43
ROE-39.5%
ROA-37.1%
Dividend yield0.00%
Debt/Equity0.00
EV/EBITDA-4.00
| week | 1M | 3M | 6M | 1Y | YTD |
|---|---|---|---|---|---|
| -10.43% | -17.27% | +7.85% | +26.38% | +19.77% | +5.64% |
Valuation and profitability in USD, latest reported 2026-09-24. Period returns are price-based.
⚖️ AI Bull vs Bear
14d momentum -17.60%, daily vol 2.85%. Inhibikase Therapeutics, Inc. Common Stock sits in a bearish regime.
Derived from 14-day momentum and daily volatility on real OHLCV.
🗞 Related News
No recent news.